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580 Abstracts February 2015comorbidity index in P2 (vs P1) in both cohorts (P < .001). Mortality
trends are depicted in Fig 1. There was a signiﬁcant decline in IHM for
all vascular patients during both time intervals, although no signiﬁcant dif-
ference in the rate of decline was noted (Table). There was no signiﬁcant
difference in IHM trends in P1 between MA and NMA; however, a signif-
icantly higher decrease in IHM was noted in MA compared with NMA in
P2 (the annual odds ratio of IHM differed by 18%; P ¼ .010).
Conclusions: Overall, a signiﬁcant decrease in IHM for all vascular
procedures was noted in the United States. The decline in postoperative
IHM was signiﬁcantly more rapid in the MA sample after 2006 compared
with the NMA sample. This study suggests that better access to care in Mas-
sachusetts may be a cause of this decline in IHM.
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Doros: None; A. Farber: None.Integrated Vascular Surgery Residency: A Look at
Electronic Residency Application Service Applicant
Numbers and National Residency Matching Program
Match OutcomesTable. Outcome of staged hybrid repair of extent I/II thoracoabdominal
aortic aneurysms (TAAAs)
Outcome Staged hybrid repairs (N ¼ 19), No. (%)
Stage 1: TEVAR
Death 0 (0)
Stroke/paraplegia 0 (0)
Acute kidney injury 1 (5.2)
Type I endoleak 2 (10.5)
Type II endoleak 1 (5.2)
Stage 2: Open distal repair
Death 0 (0)
Stroke/paraplegia 1 (5.2)
Acute kidney injurya 5 (26.3)
Chronic renal failure 0 (0)
TEVAR, Thoracic endovascular aneurysm repair.
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Objectives: In 2007 the Accreditation Council for Graduate Medical
Education granted accreditation to three vascular surgery integrated resi-
dencies. This number grew to 44 programs offering 51 positions by the
2014 match. In this study, we sought to identify the top U.S. domestic
medical schools guiding seniors into 0+5 vascular surgery programs and
ascertain which characteristics of their faculty and curriculum might be
responsible for fostering this interest.
Methods: Every U.S. medical school and its associated surgery
department was queried between January 2 and February 26, 2014. Among
the 21 data points collected were specialty of the surgery department chair,
number of vascular surgeons on staff, and option for a third-year vascular
surgery (VS) clerkship. Electronic Residency Application Service (ERAS)
and National Residency Matching Program databases were accessed and
queried. Data regarding number of integrated vascular applicants from
each medical school was obtained by special request directly from ERAS.
Results: Between 2007 and 2014, 505 students applied to an inte-
grated vascular residency via the National Residency Matching Program
(Table), whereas ERAS reported 1476 applicants during the same time
period. Of the 138 U.S. medical schools, 119 (86%) had at least one grad-
uating senior apply through ERAS to a vascular 0+5 program. U.S. gradu-
ating seniors from the top 10 schools provided 21% (107 of 512) of the total
applicants during these years. The presence of an integrated training pro-
gram (P ¼ .005) and a VS clerkship (P < .05) correlated with a higher num-
ber of applicants to 0+5 programs. Conversely, having a vascular surgeon as
the department head for general surgery was a negative predictor of student
applications to 0+5 vascular programs (odds ratio, 0.15; 95% conﬁdence in-
terval, 0.04-0.56; P ¼ .005).
Conclusions: This study emphasizes the need to fostermedical student
interest in vascular surgery through formal VS clerkships, mentorship, and tar-
geting information about the 0+5 pathway to schools producing a lower num-
ber of applicants. The negative correlation between integrated vascular
applicants and vascular surgeons serving as general surgery department chairs
may be related to the latter’s preference for the traditional 5+2 pathway.
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Year
Programs
(No.)
Positions
(No.)
Positions
ﬁlled (No.)
Total
App. (No.)
2007 3 4 4 N/A
2008 7 9 9 31
2009 17 19 19 66
2010 20 22 21 72
2011 27 30 29 80
2012 35 41 41 82
2013 39 46 45 84
2014 44 51 46 90
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Objectives: Open repair of Crawford extent I/II thoracoabdominal
aortic aneurysms (TAAA) is associated with a high rate of major adverse
complications. Staged hybrid repair of these extensive TAAAs may reduce
this operative risk. In the present study, we reviewed the midterm outcomes
of a previously described technique that combines proximal thoracic endo-
vascular aneurysm repair (TEVAR), followed by staged distal open thora-
coabdominal repair for patients with Crawford extent I/II TAAAs.
Methods: From July 2007 to June 2014, 19 patients with Crawford
extent I (n ¼ 1) or extent II (n ¼ 18) TAAAs secondary to chronic aortic
dissections underwent a staged hybrid repair. All patients had TEVAR as
stage 1 and open repair as stage 2, with partial cardiopulmonary bypass
via left femoral arterial and venous cannulation for visceral and lower
body perfusion. The open thoracoabdominal graft was anastomosed proxi-
mally in end-to-end fashion with the endograft.
Results: Patients (14 males) were an average age of 54 6 17.6 years.
Nine patients had prior open proximal aortic surgery for type 1 aortic dissec-
tions. TEVAR was performed via percutaneous (n ¼ 8), femoral cutdown (n
¼ 8), or iliac exposure (n ¼ 3). The left subclavian artery was covered in
nine patients and revascularized in eight patients by carotid-subclavian
bypass (n ¼ 7) or laser fenestration (n ¼ 1). There were no deaths, strokes,
or paralysis in this cohort. After TEVAR, three patients required repeat
intervention for endoleak (type IA, n ¼ 1; type IB, n ¼ 1; type II, n ¼
1) before open repair. After open repair, there was a single delayed perma-
nent paralysis. Hospital length of stay was 7 6 4 days after TEVAR and 9 6
5 days after open repair. No deaths or neurologic events occurred in the
remaining 18 patients over a median 85-week follow up (range 4 weeks-
6.2 years). Importantly, all patients had a stable aortic size and remained
free of reintervention during the follow-up period (Table).
Conclusions: Staged hybrid repair, combining proximal TEVAR with
open distal repair, for extensive TAAAs secondary to chronic dissection is an
effective, durable, and safe alternative to traditional open repair. This
midterm follow up data suggests that staged repair may reduce perioperative
morbidity and mortality in patients with extensive TAAAs.sidency Matching Program match
U.S. Grad
App. (No.)
IM Grad
App. (No.)
App. per
position (No.)
U.S. Grad App.
per position (No.)
N/A N/A N/A N/A
21 10 3.4 2.3
32 34 3.5 1.7
39 33 3.3 1.8
47 33 2.7 1.6
55 27 2.0 1.3
49 35 1.8 1.1
48 42 1.8 0.9
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Objectives: Aortobifemoral graft (ABFG) infections presenting with
single-limb involvement can be managed with unilateral limb excision or
complete graft removal. This study aimed to identify factors predictive of
subsequent contralateral limb infection in patients initially undergoing uni-
lateral limb excision.
Methods: A retrospective review of patients treated for infected
ABFGs from 2001 to July 2014 was performed. Endovascular and aortic
tube graft infections were excluded. Primary outcomes were freedom
from contralateral graft limb excision, overall survival, and factors potentially
predictive of subsequent contralateral limb infection.
Results: Fifteen patients underwent unilateral graft limb excision
with retroperitoneal exploration of the affected ABFG limb and revascu-
larization for unilateral graft limb infection. Original indication for
placement of the ABFG was aortoiliac occlusive disease in 11 patients
and aneurysm in four. No patients had clinical or radiographic evidence
for contralateral limb infection at initial presentation. Seven patients, all
of whom underwent initial operation for aortoiliac occlusive disease
developed contralateral limb infection at a median follow-up of 23.2
months. The remaining eight patients had no evidence of contralateral
limb infection at median follow-up of 38.8 months. Patient demo-
graphics were similar between the two groups. Five of the seven patients
who developed contralateral limb infection had imaging evidence of ipsi-
lateral graft infection above the inguinal ligament at the time of initial
graft infection. Operative exploration during unilateral excision in this
group revealed a well-incorporated graft without extension to the bifur-
cation. There was no dominant organism cultured in either group, and
duration of targeted antibiotic therapy was similar in both groups ($6
weeks). For the series, there were no amputations, and overall mortality
was 40% with median follow-up of 44.7 months.
Conclusions: Unilateral infection of an ABFG can be managed with
single-limb excision; however, 50% of patients will return with contralateral
limb infection at a median of 2 years. Clinical assessment of graft incorpora-
tion lacks speciﬁcity and does not indicate freedom from contralateral limb
infection. Factors predicting contralateral involvement include initial opera-
tion for aortoiliac occlusive disease and initial imaging or operative ﬁndings
suspicious for infection above the inguinal ligament of the unilateral limb.
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Objectives: This study reviewed the outcomes of percutaneous endo-
vascular aortic repair (PEVAR) of complex aortic aneurysms using large-
diameter sheaths for thoracic, fenestrated, and branched stent grafts.
Methods: We reviewed the outcomes of all consecutive patients who
underwent PEVAR of descending thoracic (DTA), thoracoabdominal
(TAAA), pararenal (PRA) or aortoiliac aneurysms (AIAs) using large-diam-
eter sheaths for placement of thoracic, fenestrated, or branched stent grafts.
Patients treated by fenestrated and branched stent grafts were enrolled in pro-
spective physician-sponsored investigational device exemption protocols. A
percutaneous approach was selected in patients with <50% posterior, minimal
anterior, or no calciﬁcation in the common femoral artery using standardized
preclosure technique with two Perclose devices (Abbott Vascular Inc., Red-
wood City, Calif) in each femoral puncture site. End points were technical
success, conversion to open femoral artery repair, 30-day mortality and major
adverse events, and freedom from femoral access-site complications.
Results: There were 102 patients treated for 48 PRAs, 27 TAAAs, 19
DTAs, and 8 AIAs. A total of 171 femoral arteries were closed using preclo-
sure technique. Transfemoral sheath size was 18F in four vessels (3%), 20F
in 120 (70%), and $22F in 47 (27%). Eighty-three patients (81%) had
visceral branch incorporation, which required brachial artery access using
small incision in 48. Technical success for percutaneous transfemoral closurewas 95% (162 of 171). Nine intraoperative failures were managed by open
femoral conversion using primary repair in six, interposition graft in two,
and patch angioplasty in one. Mean estimated blood loss was 444 6 569
mL. There were no patients with uncontrolled puncture-related hemor-
rhage, retroperitoneal hematoma, or intra-operative hypotension. The 30-
day mortality was 0.9% (one of 101) and 30-day rate of major adverse events
was 15% (16 of 102). Spinal cord injury occurred in one patient (0.9%). Five
(3%) access-related complications occurred, including femoral artery occlu-
sion in three and hematoma or pseudoaneurysm in one each. Wound-
related complications occurred in one patient (0.5%) who required open
femoral artery conversion for exposure and repair. After a mean follow up
of 1-year, freedom from femoral access-site complication was 97% 6 2%.
Conclusions: PEVARusing thepreclosure technique is safe and effective
in select patients with complex aortic aneurysms who have minimal or no
femoral calciﬁcations and require large-diameter sheaths for thoracic, fenes-
trated, and branched stent grafts. Rate of puncture (3%) and wound-related
complications (0.5%) is low,andnouncontrolledpuncture-relatedhemorrhage,
retroperitoneal hematoma, or systemic hypotension occurred in this series.
Author Disclosures: L. Reis de Souza: None; G. S. Oderich: (A) Com-
mercial Interest: Cook Medical; Type of Relationship: Consulting Fees paid
to Mayo Clinic; (B) Commercial Interest: WL Gore; Type of Relationship:
Consulting Fees paid to Mayo Clinic; (C) Commercial Interest: Atrium
Maquet; Type of Relationship: Research Grant; (D) Commercial Interest:
Cook Medical; Type of Relationship: Research Grant; (E); Commercial In-
terest: W. L. Gore & Associates; Type of Relationship: Research Grant. P.
Banga: None; J. Hofer: None; S. Cha: None; P. Gloviczki: None.Left Subclavian Artery Occlusion During Thoracic
Endovascular Aortic Repair in the Elderly Is Associated
With Signiﬁcant Morbidity
Khanjan H. Nagarsheth, MD, Jonathan Schor, MD, Matthew
D’Alessandro, DO, Kuldeep Singh, MD, Jonathan Deitch, MD. Staten
Island University Hospital, Staten Island, NY
Objectives: Covering the left subclavian artery (LSA) during thoracic
endovascular aortic repair (TEVAR) for proximal seal is generally safe and
well tolerated. The purpose of this study was to determine if this practice
is safe in elderly patients.
Methods: The National Surgical Quality Improvement Program
(NSQIP) database was queried, from the years 2005 to 2011, to identify pa-
tients who underwent TEVAR. Octogenarians were separated into two
groups, one where the LSA was covered (C-SA) and another where it was
not covered (U-SA). Patient demographics, comorbidities, perioperative
data, and outcomes were compared.
Results: There were 392 patients aged >80 who underwent TEVAR,
128 patients in the C-SA group and 264 in the U-SA group. There was no
signiﬁcant difference in demographics or baseline cardiovascular or pulmo-
nary comorbidities between groups. There was also no difference in emer-
gency procedures between C-SA and U-SA groups (27% vs 21%; P ¼
.18). The C-SA group had signiﬁcantly more intraoperative cardiac arrest
(4% vs 1%; P ¼ .03) and signiﬁcantly more received intraoperative blood
transfusions (32% vs 21%; P ¼ .02). There was also a higher postoperative
rate of stroke (9% vs 3%; P ¼ .03) and sepsis (9% vs 3%; P < .01) in the
C-SA group compared with the U-SA group.
Conclusions: Covering the LSA in octogenarians is associated with
signiﬁcantly increased perioperative morbidity. We recommend caution
when considering coverage of the LCA during TEVAR. These patients
may beneﬁt from elective revascularization when possible.
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Objectives: Aortic dissection is a dynamic process that can extend
distal to the entry tear or proximally in a retrograde fashion. We sought
to determine associations for development of new acute type A aortic dissec-
tion (ATAD) after type B dissection (TBAD).
Methods: We reviewed our aortic dissection database for cases of
ATAD from 2002 to 2013 that had known TBAD. Imaging and intraoper-
ative reports were used to determine presence of entry tear with dissection
